MSH2 and cancer: The predominant dysfunctions identified in cancers exhibiting DNA mismatch repair deficit is the lack of MutL homolog 1/Postmeiotic segregation enhanced two (MLH1/PMS2) and/or MutL homolog 2/MutL homolog six expression(MSH2/MSH6)28.